Company intelligence / Profile preview

Luna Bioscience

Westport, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Luna Bioscience has identified novel antigens that mediate vaccine protection from leptospira. Proof-of-principle has been demonstrated in two animal models. Dog safety and immunogenicity trials are complete; the company is preparing for pivotal dog studies and an IND submission for a Phase 1 human clinical trial. The company also integrates diagnostic tests with its vaccines as part of its product offering.

Therapeutic areas: Infectious Diseases
Modalities: VaccineDiagnostic test
Industry: Biotech

Partnerships

Seeking strategic partners and funding

Beyond the preview

Go deeper on Luna Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luna Bioscience.

Explore the full profile